Boyraz Alperen, Candemir Burcu, Akın Şafak, Candemir Mustafa, Gülçelik Neşe Ersöz
Department of Internal Medicine, Gulhane Faculty of Medicine, University of Health Sciences, Ankara, Turkey.
Department of Endocrinology and Metabolism, Gulhane Faculty of Medicine, University of Health Sciences, Ankara, Turkey.
Ann Endocrinol (Paris). 2025 Apr;86(2):101687. doi: 10.1016/j.ando.2025.101687. Epub 2025 Jan 11.
Non-functional adrenal incidentaloma (NFAI) is associated with an increased risk of adverse cardiometabolic outcome. Identifying predictors of atherosclerotic cardiovascular disease (ASCVD) may enable more appropriate management strategies in patients with NFAI. We aimed to investigate the body composition parameters and ASCVD risk in patients with NFAI.
Eighty patients with NFAI and 80 controls matched for age, gender and body mass index (BMI) were included. ASCVD risk was assessed on Framingham Risk Score (FRS) and American Heart Association/American College of Cardiology (AHA/ACC) score. Body composition was evaluated using a segmental body composition analyzer.
There were no significant differences in age, gender, blood pressure or body composition parameters between the two groups. Patients with NFAI had higher FRS and AHA/ACC scores than controls (P=0.017, P=0.024, respectively). In patients with NFAI, independent predictors for FRS were serum cortisol level after 1mg dexamethasone suppression test (DST) and waist/hip ratio (WHR), while independent predictors for AHA/ACC score were serum cortisol level after 1mg DST, WHR and fasting plasma glucose (FPG), in various multivariate linear regression models.
FRS and AHA/ACC scores may be useful in determining ASCVD risk in patients with NFAI, and serum cortisol level after 1mg DST is an independent predictor of ASCVD in these patients, even in the absence of hypercortisolism.
无功能肾上腺偶发瘤(NFAI)与不良心脏代谢结局风险增加相关。识别动脉粥样硬化性心血管疾病(ASCVD)的预测因素可能有助于对NFAI患者采取更合适的管理策略。我们旨在研究NFAI患者的身体成分参数和ASCVD风险。
纳入80例NFAI患者和80例年龄、性别及体重指数(BMI)相匹配的对照者。采用弗明汉风险评分(FRS)和美国心脏协会/美国心脏病学会(AHA/ACC)评分评估ASCVD风险。使用分段身体成分分析仪评估身体成分。
两组在年龄、性别、血压或身体成分参数方面无显著差异。NFAI患者的FRS和AHA/ACC评分高于对照组(分别为P = 0.017,P = 0.024)。在各种多元线性回归模型中,对于NFAI患者,FRS的独立预测因素是1mg地塞米松抑制试验(DST)后的血清皮质醇水平和腰臀比(WHR),而AHA/ACC评分的独立预测因素是1mg DST后的血清皮质醇水平、WHR和空腹血糖(FPG)。
FRS和AHA/ACC评分可能有助于确定NFAI患者的ASCVD风险,1mg DST后的血清皮质醇水平是这些患者ASCVD的独立预测因素,即使在无皮质醇增多症的情况下也是如此。